United approach needed to counter rising tide of fake drugs
This article was originally published in Scrip
Executive Summary
As counterfeiters become more sophisticated and their products more difficult to detect, the traffic in fake medicines is on the increase. Efforts are being made to tackle the trade but, as Ian Schofield finds, they are being hindered by the lack of a harmonised approach, controversy over intellectual property issues, and the increasing use of the internet as a conduit for counterfeit medicines.